163 related articles for article (PubMed ID: 2014965)
21. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
Hostacká A
J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
23. Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
Lewis DA; Hawkey PM; WattsJA ; Speller DC; Primavesi RJ; Fleming PJ; Pitt TL
Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1701-5. PubMed ID: 6315130
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.
Cremieux AC; Saleh-Mghir A; Vallois JM; Maziere B; Muffat-Joly M; Devine C; Bouvet A; Pocidalo JJ; Carbon C
Antimicrob Agents Chemother; 1992 Oct; 36(10):2216-21. PubMed ID: 1332590
[TBL] [Abstract][Full Text] [Related]
25. In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.
Juvin ME; Potel G; Caillon J; Xiong YQ; Bugnon D; Le Conte P; Baron DI; Drugeon HB
Antimicrob Agents Chemother; 1994 Apr; 38(4):883-5. PubMed ID: 8031065
[TBL] [Abstract][Full Text] [Related]
26. A laboratory assessment of the activities of four aminoglycosides.
Schrire L; Robinson RG; Koornhof HJ
S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
[TBL] [Abstract][Full Text] [Related]
28. Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci.
Bouvet A; Cremieux AC; Contrepois A; Vallois JM; Lamesch C; Carbon C
Antimicrob Agents Chemother; 1985 Nov; 28(5):607-11. PubMed ID: 4091526
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage.
Muscato JJ; Wilbur DW; Stout JJ; Fahrlender RA
J Antimicrob Chemother; 1991 May; 27 Suppl C():1-7. PubMed ID: 1906860
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
Maslow MJ; Simberkoff MS; Rahal JJ
J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
[TBL] [Abstract][Full Text] [Related]
31. Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility.
Zavascki AP; Klee BO; Bulitta JB
Expert Rev Anti Infect Ther; 2017 Jun; 15(6):519-526. PubMed ID: 28375030
[TBL] [Abstract][Full Text] [Related]
32. In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model.
Robaux MA; Dube L; Caillon J; Bugnon D; Kergueris MF; Navas D; Le Conte P; Baron D; Potel G
J Antimicrob Chemother; 2001 May; 47(5):617-22. PubMed ID: 11328773
[TBL] [Abstract][Full Text] [Related]
33. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity.
Garraffo R; Drugeon HB; Dellamonica P; Bernard E; Lapalus P
Antimicrob Agents Chemother; 1990 Apr; 34(4):614-21. PubMed ID: 2111658
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection.
Blaser J
J Antimicrob Chemother; 1991 May; 27 Suppl C():21-8. PubMed ID: 1906863
[TBL] [Abstract][Full Text] [Related]
35. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
Strausbaugh LJ; Mandaleris CD; Sande MA
J Lab Clin Med; 1977 Apr; 89(4):692-701. PubMed ID: 321713
[TBL] [Abstract][Full Text] [Related]
36. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
Agence française de sécurité sanitaire des produits de santé
Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
[No Abstract] [Full Text] [Related]
37. Hydrophobicity and outer membrane proteins of Shigella dysenteriae type 1 after treatment with subinhibitory concentrations of aminoglycosides.
Hostacká A; Karelová E
Folia Microbiol (Praha); 1997; 42(6):565-8. PubMed ID: 9438357
[TBL] [Abstract][Full Text] [Related]
38. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
Moellering RC; Wennersten C; Kunz LJ; Poitras JW
Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
[TBL] [Abstract][Full Text] [Related]
39. [Experimental Enterobacter cloacae endocarditis treated with gentamicin. Predictive value of the in vitro bactericidal rate].
Potel G; Caillon J; Bugnon D; Lecomte P; Drugeon HB; Baron D
Pathol Biol (Paris); 1988 May; 36(5):536-9. PubMed ID: 3043353
[TBL] [Abstract][Full Text] [Related]
40. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
Watanakunakorn C; Kauffman CA
Infection; 1978; 6(3):111-5. PubMed ID: 98451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
